ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.575,94
0,86%
S&P 500
5.347,53
1,06%
Dow Jones
38.829,71
0,31%
Euro vs US Dollar
1,08716
-0,09%
Bitcoin
71.073,00
0,63%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Passage Bio Inc (PASG)

  7. Passage Bio Inc (PASG) News

PASG

Passage Bio (PASG)

Passage Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PASG
DatumZeitQuelleÜberschriftSymbolFirma
05/06/202413h30GlobeNewswire Inc.Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:PASGPassage Bio Inc
23/05/202422h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
22/05/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
21/05/202414h00GlobeNewswire Inc.Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship AwardNASDAQ:PASGPassage Bio Inc
14/05/202414h15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PASGPassage Bio Inc
14/05/202413h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
14/05/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
14/05/202413h00GlobeNewswire Inc.Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
22/04/202413h00GlobeNewswire Inc.Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:PASGPassage Bio Inc
05/03/202413h00GlobeNewswire Inc.Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship ProgramNASDAQ:PASGPassage Bio Inc
04/03/202423h22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PASGPassage Bio Inc
04/03/202422h09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PASGPassage Bio Inc
04/03/202413h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PASGPassage Bio Inc
04/03/202413h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
04/03/202413h00GlobeNewswire Inc.Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
29/02/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
27/02/202413h00GlobeNewswire Inc.Passage Bio to Participate in Upcoming Investor ConferencesNASDAQ:PASGPassage Bio Inc
14/02/202415h21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PASGPassage Bio Inc
14/02/202401h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
14/02/202401h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
05/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
03/01/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
03/01/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
03/01/202422h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
29/12/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
20/12/202313h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
20/12/202313h00GlobeNewswire Inc.Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic PrioritiesNASDAQ:PASGPassage Bio Inc
17/11/202322h30GlobeNewswire Inc.Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:PASGPassage Bio Inc
13/11/202313h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
13/11/202313h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PASG

Kürzlich von Ihnen besucht

BIT
P1W8T8
NLBNPIT1W8T8 20240621 9.5
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten